Explore the new executive order signed by President Trump aimed at reducing drug prices and improving Medicare transparency. Understand its impact on healthcare costs and policy continuity in U.S. healthcare.
Explore the complexities of Colorado's Medicaid funding structure and its implications for state health coverage, including FMAP discrepancies among populations.
President Trump signs an executive order to lower U.S. prescription drug prices, amending key Medicare negotiations. Learn how this could impact the healthcare and insurance sectors.
Exploring the challenges faced by rural hospitals with Medicare Advantage contracts, including lower reimbursement rates and resource-intensive administrative processes.
CMS has announced a significant 5.06% payment increase for Medicare Advantage plans for 2026, improving financial support amidst rising healthcare costs.
MedPAC estimates that Medicare Advantage costs will exceed traditional Medicare by $84 billion, affecting future healthcare policy.
Discover the growing physician shortage crisis in the U.S. and proposed solutions for healthcare reform.
Without an extension of premium tax credits, millions may lose their health insurance. This analysis highlights the potential healthcare crisis ahead.
The OIG warns of inaccuracies in Medicare Advantage risk payments linked to health assessments, proposing CMS audits and stricter regulations.
Ceci Connolly discusses key aspects of the 2024 election's implications for the healthcare industry, focusing on drug pricing, telehealth, and the dynamics between major candidates.
